Literature DB >> 2535735

Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability.

H C Wang1, J T Parsons.   

Abstract

We previously showed (V. W. Raymond and J. T. Parsons, Virology 160:400-410, 1987) that variants of the Prague A strain of Rous sarcoma virus containing large deletions impinging on a region of the src gene encoding amino acid residues 143 to 169 were defective for transformation of chicken cells in culture. Here we report that introduction of small (tri-and tetrapeptide) deletions into a region of pp60v-src containing amino acid residues 155 to 175 was found to inactivate transformation. In addition, insertion of four, but not one, amino acid residues at position 161 also inhibited transformation. Biochemical analysis of the src proteins encoded by individual transformation-defective variants revealed that the structural alterations introduced into this domain had only marginal effects upon src tyrosine-specific protein kinase activity. However, the src proteins encoded by defective variants exhibited a significantly shorter half-life within the cell, although these proteins efficiently and rapidly associated with cellular membranes. Our results suggest that the structural domain encompassing residues 155 to 177 may influence the stability of pp60src in the cellular membrane, possibly via the interaction of src with a cellular membrane component(s) or substrate(s).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535735      PMCID: PMC247684     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

2.  Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases.

Authors:  R Hirst; A Horwitz; C Buck; L Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Phosphorylation of tyrosine residues of calmodulin in Rous sarcoma virus-transformed cells.

Authors:  Y Fukami; T Nakamura; A Nakayama; T Kanehisa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene.

Authors:  F R Cross; E A Garber; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

Review 5.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins.

Authors:  J S Brugge; D Darrow
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

7.  Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites.

Authors:  M P Kamps; S S Taylor; B M Sefton
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

8.  Amino acid alterations within a highly conserved region of the Rous sarcoma virus src gene product pp60src inactivate tyrosine protein kinase activity.

Authors:  D L Bryant; J T Parsons
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

9.  A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation.

Authors:  F R Cross; E A Garber; D Pellman; H Hanafusa
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

10.  The stimulation of pp60v-src kinase activity by vanadate in intact cells accompanies a new phosphorylation state of the enzyme.

Authors:  D J Brown; J A Gordon
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

View more
  29 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

4.  The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.

Authors:  C A Koch; M Moran; I Sadowski; T Pawson
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

5.  Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein.

Authors:  A H Bouton; S B Kanner; R R Vines; H C Wang; J B Gibbs; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

6.  Identification and characterization of a novel cytoskeleton-associated pp60src substrate.

Authors:  H Wu; A B Reynolds; S B Kanner; R R Vines; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

7.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src.

Authors:  J S Moyers; A H Bouton; S J Parsons
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.

Authors:  C Seidel-Dugan; B E Meyer; S M Thomas; J S Brugge
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases.

Authors:  S M Bell; D C Connolly; N J Maihle; J L Degen
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.